Fate Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
13.30 |
4.17 |
3.18 |
3.41 |
4.54 |
39.56 |
| Przychód Δ r/r |
0.00% |
-68.64% |
-23.71% |
7.13% |
33.14% |
772.02% |
| Przychód (min) |
12.38 |
3.71 |
1.75 |
1.87 |
2.49 |
21.71 |
| Przychód (max) |
15.78 |
4.63 |
6.36 |
6.81 |
9.07 |
79.12 |
| EBITDA (średnia) |
-13.30 |
-4.17 |
-3.18 |
-3.41 |
-4.54 |
-39.56 |
| EBIT (średnia) |
-13.30 |
-4.17 |
-3.18 |
-3.41 |
-4.54 |
-39.56 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-175.88 |
-152.43 |
-175.11 |
-200.02 |
-189.10 |
-159.54 |
| Zysk netto % |
-1322.68% |
-3656.01% |
-5505.65% |
-5870.10% |
-4168.17% |
-403.27% |
| EPS (średnia) |
-1.62 |
-1.34 |
-1.30 |
-1.20 |
-1.66 |
-1.40 |
| Liczba analityków (Przychody) |
10 |
6 |
9 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
11 |
10 |
10 |
4 |
3 |
2 |
| symbol |
FATE |
FATE |
FATE |
FATE |
FATE |
FATE |